Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velcade in Relapsed/Refractory Multiple Myeloma with Renal Impairment
NCT00718640Phase 2Terminated
- Sponsor
- Janssen Ortho
- Start
- Oct 2007
- Primary completion
- Dec 2009
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in multiple myeloma (MM), sponsored by Janssen Ortho. Started Oct 2007; status: terminated.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00718640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00718640.